|
|
||||||||
The FASEB Journal, Vol 9, 974-980, Copyright © 1995 by The Federation of American Societies for Experimental Biology
RESEARCH COMMUNICATIONS |
ZS Galis, GK Sukhova and P Libby
Vascular Medicine and Atherosclerosis Unit, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Many physiological and pathological processes involve tissue remodeling due in part to degradation of extracellular matrix. Several factors limit current approaches used for detection of matrix-degrading enzymes in tissues. Matrix metalloproteinases (MMPs), enzymes specialized in catabolism of extracellular matrix constituents, require processing from inactive zymogen precursors to gain enzymatic function. Presently available antibodies do not distinguish between precursor and proteolytically processed forms of MMPs. Also, ubiquitous tissue inhibitors of metalloproteinases (TIMPs) could prevent matrix degradation by MMPs even if the enzymes were in an active form. For these reasons immunocytochemistry does not provide information regarding the functional state of these enzymes. Biochemical studies of tissue extracts preclude localization and entail the possibility of artifactual activation of the enzymes consequent to tissue disruption. To obviate these problems, we have adapted substrate zymography to frozen tissue sections to assess net proteolytic activity in situ. We report here the details and the validation of this methodology. Initial experiments defined casein fluorescently labeled with resorufin as a useful substrate for detecting stromelysin, and fluoresceinated gelatin or autoradiographic emulsion as suitable for detecting gelatinolytic activity by this approach. Either TIMP-1 or the Zn chelator 1,10- phenanthroline reduced the zymographic activity in cryosections of atheroma from humans or rabbits. Inhibitors of serine proteases did not reduce the extent of substrate lysis substantially. In situ zymography preserves the fine morphological details of the tissue and can complement the study of enzyme expression by other microscopic techniques, such as immunocytochemistry. This approach may prove generally applicable for the detection of protease activity in tissue sections permitting exploration of the roles of these enzymes in pathobiology.
This article has been cited by other articles:
![]() |
E. Lancelot, V. Amirbekian, I. Brigger, J.-S. Raynaud, S. Ballet, C. David, O. Rousseaux, S. Le Greneur, M. Port, H. R. Lijnen, et al. Evaluation of Matrix Metalloproteinases in Atherosclerosis Using a Novel Noninvasive Imaging Approach Arterioscler. Thromb. Vasc. Biol., March 1, 2008; 28(3): 425 - 432. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Aitken, G. Block, A. Lorenzo, D. Herz, N. Sabha, O. Dessouki, F. Fung, M. Szybowska, L. Craig, and D. J. Bagli Mechanotransduction of Extracellular Signal-Regulated Kinases 1 and 2 Mitogen-Activated Protein Kinase Activity in Smooth Muscle Is Dependent on the Extracellular Matrix and Regulated by Matrix Metalloproteinases Am. J. Pathol., August 1, 2006; 169(2): 459 - 470. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Johnson, A. H. Baker, K. Oka, L. Chan, A. C. Newby, C. L. Jackson, and S. J. George Suppression of Atherosclerotic Plaque Progression and Instability by Tissue Inhibitor of Metalloproteinase-2: Involvement of Macrophage Migration and Apoptosis Circulation, May 23, 2006; 113(20): 2435 - 2444. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P.G. Sluijter, D. P.V. de Kleijn, and G. Pasterkamp Vascular remodeling and protease inhibition-bench to bedside Cardiovasc Res, February 15, 2006; 69(3): 595 - 603. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Dollery and P. Libby Atherosclerosis and proteinase activation Cardiovasc Res, February 15, 2006; 69(3): 625 - 635. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wang, J. Zhang, G. Spinetti, L.-Q. Jiang, R. Monticone, D. Zhao, L. Cheng, M. Krawczyk, M. Talan, G. Pintus, et al. Angiotensin II Activates Matrix Metalloproteinase Type II and Mimics Age-Associated Carotid Arterial Remodeling in Young Rats Am. J. Pathol., November 1, 2005; 167(5): 1429 - 1442. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Krams, S. Verheye, L. C.A. van Damme, D. Tempel, B. M. Gourabi, E. Boersma, M. M. Kockx, M. W.M. Knaapen, C. Strijder, G. van Langenhove, et al. In vivo temperature heterogeneity is associated with plaque regions of increased MMP-9 activity Eur. Heart J., October 2, 2005; 26(20): 2200 - 2205. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kang, S. Cho, J. H. Chung, C. Hammerberg, G. J. Fisher, and J. J. Voorhees Inflammation and Extracellular Matrix Degradation Mediated by Activated Transcription Factors Nuclear Factor-{kappa}B and Activator Protein-1 in Inflammatory Acne Lesions in Vivo Am. J. Pathol., June 1, 2005; 166(6): 1691 - 1699. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Mehrzad, C. Desrosiers, K. Lauzon, G. Robitaille, X. Zhao, and P. Lacasse Proteases Involved in Mammary Tissue Damage During Endotoxin-Induced Mastitis in Dairy Cows J Dairy Sci, January 1, 2005; 88(1): 211 - 222. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. M. Frederiks and O. R.F. Mook Metabolic Mapping of Proteinase Activity with Emphasis on In Situ Zymography of Gelatinases: Review and Protocols J. Histochem. Cytochem., June 1, 2004; 52(6): 711 - 722. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Gong, A. Rifai, E. M. Tolbert, J. N. Centracchio, and L. D. Dworkin Hepatocyte Growth Factor Modulates Matrix Metalloproteinases and Plasminogen Activator/Plasmin Proteolytic Pathways in Progressive Renal Interstitial Fibrosis J. Am. Soc. Nephrol., December 1, 2003; 14(12): 3047 - 3060. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. E. Sobel, D. J. Taatjes, and D. J. Schneider Intramural Plasminogen Activator Inhibitor Type-1 and Coronary Atherosclerosis Arterioscler. Thromb. Vasc. Biol., November 1, 2003; 23(11): 1979 - 1989. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Hundal, A. Gomez-Munoz, J. Y. Kong, B. S. Salh, A. Marotta, V. Duronio, and U. P. Steinbrecher Oxidized Low Density Lipoprotein Inhibits Macrophage Apoptosis by Blocking Ceramide Generation, Thereby Maintaining Protein Kinase B Activation and Bcl-XL Levels J. Biol. Chem., June 27, 2003; 278(27): 24399 - 24408. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. R.F. Mook, C. Van Overbeek, E. G. Ackema, F. Van Maldegem, and W. M. Frederiks In Situ Localization of Gelatinolytic Activity in the Extracellular Matrix of Metastases of Colon Cancer in Rat Liver Using Quenched Fluorogenic DQ-gelatin J. Histochem. Cytochem., June 1, 2003; 51(6): 821 - 829. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M Aguilera, S. J George, J. L Johnson, and A. C Newby Relationship between type IV collagen degradation, metalloproteinase activity and smooth muscle cell migration and proliferation in cultured human saphenous vein Cardiovasc Res, June 1, 2003; 58(3): 679 - 688. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Yan and E. A. G. Blomme In Situ Zymography: A Molecular Pathology Technique to Localize Endogenous Protease Activity in Tissue Sections Vet. Pathol., May 1, 2003; 40(3): 227 - 236. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-J. Boffa, Y. Lu, S. Placier, A. Stefanski, J.-C. Dussaule, and C. Chatziantoniou Regression of Renal Vascular and Glomerular Fibrosis: Role of Angiotensin II Receptor Antagonism and Matrix Metalloproteinases J. Am. Soc. Nephrol., May 1, 2003; 14(5): 1132 - 1144. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Luan, A. J. Chase, and A. C. Newby Statins Inhibit Secretion of Metalloproteinases-1, -2, -3, and -9 From Vascular Smooth Muscle Cells and Macrophages Arterioscler. Thromb. Vasc. Biol., May 1, 2003; 23(5): 769 - 775. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. K. Shah Mechanisms of plaque vulnerability and rupture J. Am. Coll. Cardiol., February 19, 2003; 41(4_Suppl_S): 15S - 22S. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. G. Lakatta Arterial and Cardiac Aging: Major Shareholders in Cardiovascular Disease Enterprises: Part III: Cellular and Molecular Clues to Heart and Arterial Aging Circulation, January 28, 2003; 107(3): 490 - 497. [Full Text] [PDF] |
||||
![]() |
A. K. Death, S. Nakhla, K. C. Y. McGrath, S. Martell, D. K. Yue, W. Jessup, and D. S. Celermajer Nitroglycerin upregulates matrix metalloproteinase expression by human macrophages J. Am. Coll. Cardiol., June 19, 2002; 39(12): 1943 - 1950. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Silence, D. Collen, and H.R. Lijnen Reduced Atherosclerotic Plaque but Enhanced Aneurysm Formation in Mice With Inactivation of the Tissue Inhibitor of Metalloproteinase-1 (TIMP-1) Gene Circ. Res., May 3, 2002; 90(8): 897 - 903. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Loftus and M. Thompson The role of matrix metalloproteinases in vascular disease Vascular Medicine, May 1, 2002; 7(2): 117 - 133. [Abstract] [PDF] |
||||
![]() |
J. Zhang and L. A. Salamonsen In Vivo Evidence for Active Matrix Metalloproteinases in Human Endometrium Supports their Role in Tissue Breakdown at Menstruation J. Clin. Endocrinol. Metab., May 1, 2002; 87(5): 2346 - 2351. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Maquoi, C. Munaut, A. Colige, D. Collen, and H. R. Lijnen Modulation of Adipose Tissue Expression of Murine Matrix Metalloproteinases and Their Tissue Inhibitors With Obesity Diabetes, April 1, 2002; 51(4): 1093 - 1101. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Arechavaleta-Velasco, J. Mayon-Gonzalez, M. Gonzalez-Jimenez, C. Hernandez-Guerrero, and F. Vadillo-Ortega Association of Type II Apoptosis and 92-kDa Type IV Collagenase Expression in Human Amniochorion in Prematurely Ruptured Membranes With Tumor Necrosis Factor Receptor-1 Expression Reproductive Sciences, March 1, 2002; 9(2): 60 - 67. [Abstract] [PDF] |
||||
![]() |
H.R. Lijnen, E. Maquoi, L.B. Hansen, B. Van Hoef, L. Frederix, and D. Collen Matrix Metalloproteinase Inhibition Impairs Adipose Tissue Development in Mice Arterioscler. Thromb. Vasc. Biol., March 1, 2002; 22(3): 374 - 379. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-L. Franco, P. Waszak, G. Banalec, M. Levame, C. Lafuma, A. Harf, and C. Delacourt Pre- and Postnatal Lung Development, Maturation, and Plasticity: LPS-induced lung injury in neonatal rats: changes in gelatinase activities and consequences on lung growth Am J Physiol Lung Cell Mol Physiol, March 1, 2002; 282(3): L491 - L500. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. S. Galis and J. J. Khatri Matrix Metalloproteinases in Vascular Remodeling and Atherogenesis: The Good, the Bad, and the Ugly Circ. Res., February 22, 2002; 90(3): 251 - 262. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Cherr, S. J. Motew, J. A. Travis, J. Fingerle, L. Fisher, M. Brandl, J. K. Williams, and R. L. Geary Metalloproteinase Inhibition and the Response to Angioplasty and Stenting in Atherosclerotic Primates Arterioscler. Thromb. Vasc. Biol., January 1, 2002; 22(1): 161 - 166. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Gushima, K. Ichikado, M. Suga, T. Okamoto, K. Iyonaga, K. Sato, H. Miyakawa, and M. Ando Expression of matrix metalloproteinases in pigs with hyperoxia-induced acute lung injury Eur. Respir. J., November 1, 2001; 18(5): 827 - 837. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. Curry Jr., L. Song, and S. E. Wheeler Cellular Localization of Gelatinases and Tissue Inhibitors of Metalloproteinases During Follicular Growth, Ovulation, and Early Luteal Formation in the Rat Biol Reprod, September 1, 2001; 65(3): 855 - 865. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Di Girolamo, M. T. Coroneo, and D. Wakefield Active Matrilysin (MMP-7) in Human Pterygia: Potential Role in Angiogenesis Invest. Ophthalmol. Vis. Sci., August 1, 2001; 42(9): 1963 - 1968. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Johnson, G. J. J. M. van Eys, G. D. Angelini, and S. J. George Injury Induces Dedifferentiation of Smooth Muscle Cells and Increased Matrix-Degrading Metalloproteinase Activity in Human Saphenous Vein Arterioscler. Thromb. Vasc. Biol., July 1, 2001; 21(7): 1146 - 1151. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bond, A. J Chase, A. H Baker, and A. C Newby Inhibition of transcription factor NF-{kappa}B reduces matrix metalloproteinase-1, -3 and -9 production by vascular smooth muscle cells Cardiovasc Res, June 1, 2001; 50(3): 556 - 565. [Abstract] [Full Text] [PDF] |
||||
![]() |
D M Braganza and M R Bennett New insights into atherosclerotic plaque rupture Postgrad. Med. J., February 1, 2001; 77(904): 94 - 98. [Full Text] |
||||
![]() |
N. Di Girolamo, D. Wakefield, and M. T. Coroneo Differential Expression of Matrix Metalloproteinases and Their Tissue Inhibitors at the Advancing Pterygium Head Invest. Ophthalmol. Vis. Sci., December 1, 2000; 41(13): 4142 - 4149. [Abstract] [Full Text] |
||||
![]() |
A. Cho, J. Graves, and M. A. Reidy Mitogen-Activated Protein Kinases Mediate Matrix Metalloproteinase-9 Expression in Vascular Smooth Muscle Cells Arterioscler. Thromb. Vasc. Biol., December 1, 2000; 20(12): 2527 - 2532. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Tarlton, C. V. Whiting, D. Tunmore, S. Bregenholt, J. Reimann, M. H. Claesson, and P. W. Bland The Role of Up-Regulated Serine Proteases and Matrix Metalloproteinases in the Pathogenesis of a Murine Model of Colitis Am. J. Pathol., December 1, 2000; 157(6): 1927 - 1935. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Mavromatis, T. Fukai, M. Tate, N. Chesler, D. N. Ku, and Z. S. Galis Early Effects of Arterial Hemodynamic Conditions on Human Saphenous Veins Perfused Ex Vivo Arterioscler. Thromb. Vasc. Biol., August 1, 2000; 20(8): 1889 - 1895. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ikeda, R. Maekawa, H. Tanaka, M. Matsumoto, Y. Takeda, Y. Tamura, R. Nemori, and T. Yoshioka Inhibition of Gelatinolytic Activity in Tumor Tissues by Synthetic Matrix Metalloproteinase Inhibitor: Application of Film in Situ Zymography Clin. Cancer Res., August 1, 2000; 6(8): 3290 - 3296. [Abstract] [Full Text] |
||||
![]() |
R. St-Arnaud, A. Arabian, R. Travers, F. Barletta, M. Raval-Pandya, K. Chapin, J. Depovere, C. Mathieu, S. Christakos, M. B. Demay, et al. Deficient Mineralization of Intramembranous Bone in Vitamin D-24-Hydroxylase-Ablated Mice Is Due to Elevated 1,25-Dihydroxyvitamin D and Not to the Absence of 24,25-Dihydroxyvitamin D Endocrinology, July 1, 2000; 141(7): 2658 - 2666. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Virmani, F. D. Kolodgie, A. P. Burke, A. Farb, and S. M. Schwartz Lessons From Sudden Coronary Death : A Comprehensive Morphological Classification Scheme for Atherosclerotic Lesions Arterioscler. Thromb. Vasc. Biol., May 1, 2000; 20(5): 1262 - 1275. [Full Text] [PDF] |
||||
![]() |
S. J. George, C. T. Lloyd, G. D. Angelini, A. C. Newby, and A. H. Baker Inhibition of Late Vein Graft Neointima Formation in Human and Porcine Models by Adenovirus-Mediated Overexpression of Tissue Inhibitor of Metalloproteinase-3 Circulation, January 25, 2000; 101(3): 296 - 304. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Fernandez-Patron, M. W. Radomski, and S. T. Davidge Vascular Matrix Metalloproteinase-2 Cleaves Big Endothelin-1 Yielding a Novel Vasoconstrictor Circ. Res., November 12, 1999; 85(10): 906 - 911. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. C. Chesler, D. N. Ku, and Z. S. Galis Transmural pressure induces matrix-degrading activity in porcine arteries ex vivo Am J Physiol Heart Circ Physiol, November 1, 1999; 277(5): H2002 - H2009. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Aukrust, F. Muller, T. Ueland, T. Berget, E. Aaser, A. Brunsvig, N. O. Solum, K. Forfang, S. S. Froland, and L. Gullestad Enhanced Levels of Soluble and Membrane-Bound CD40 Ligand in Patients With Unstable Angina : Possible Reflection of T Lymphocyte and Platelet Involvement in the Pathogenesis of Acute Coronary Syndromes Circulation, August 10, 1999; 100(6): 614 - 620. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. Zaltsman, S. J. George, and A. C. Newby Increased Secretion of Tissue Inhibitors of Metalloproteinases 1 and 2 From the Aortas of Cholesterol Fed Rabbits Partially Counterbalances Increased Metalloproteinase Activity Arterioscler. Thromb. Vasc. Biol., July 1, 1999; 19(7): 1700 - 1707. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. C. TUCKER, G. FERRY, S. PROVENT, and G. ATASSI In Situ Activity of Gelatinases during Lewis Lung Carcinoma Progression Ann. N.Y. Acad. Sci., June 30, 1999; 878(1): 534 - 537. [Full Text] [PDF] |
||||
![]() |
D. F. Gibbs, T. P. Shanley, R. L. Warner, H. S. Murphy, J. Varani, and K. J. Johnson Role of Matrix Metalloproteinases in Models of Macrophage-Dependent Acute Lung Injury . Evidence for Alveolar Macrophage as Source of Proteinases Am. J. Respir. Cell Mol. Biol., June 1, 1999; 20(6): 1145 - 1154. [Abstract] [Full Text] |
||||
![]() |
I. M. Bayer, S. L. Adamson, and B. L. Langille Atrophic Remodeling of the Artery-Cuffed Artery Arterioscler. Thromb. Vasc. Biol., June 1, 1999; 19(6): 1499 - 1505. [Abstract] [Full Text] [PDF] |
||||
![]() |
A J Freemont, R J Byers, Y O Taiwo, and J A Hoyland In situ zymographic localisation of type II collagen degrading activity in osteoarthritic human articular cartilage Ann Rheum Dis, June 1, 1999; 58(6): 357 - 365. [Abstract] [Full Text] |
||||
![]() |
B. Zhang, S. Ye, S.-M. Herrmann, P. Eriksson, M. de Maat, A. Evans, D. Arveiler, G. Luc, F. Cambien, A. Hamsten, et al. Functional Polymorphism in the Regulatory Region of Gelatinase B Gene in Relation to Severity of Coronary Atherosclerosis Circulation, April 13, 1999; 99(14): 1788 - 1794. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-P. Xu, S. R. Meisel, J. M. Ong, S. Kaul, B. Cercek, T. B. Rajavashisth, B. Sharifi, and P. K. Shah Oxidized Low-Density Lipoprotein Regulates Matrix Metalloproteinase-9 and Its Tissue Inhibitor in Human Monocyte-Derived Macrophages Circulation, March 2, 1999; 99(8): 993 - 998. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Rabbani and E. J. Topol Strategies to achieve coronary arterial plaque stabilization Cardiovasc Res, February 1, 1999; 41(2): 402 - 417. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Li, J. Froehlich, Z. S. Galis, and E. G. Lakatta Increased Expression of Matrix Metalloproteinase-2 in the Thickened Intima of Aged Rats Hypertension, January 1, 1999; 33(1): 116 - 123. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Johnson, C. L. Jackson, G. D. Angelini, and S. J. George Activation of Matrix-Degrading Metalloproteinases by Mast Cell Proteases in Atherosclerotic Plaques Arterioscler. Thromb. Vasc. Biol., November 1, 1998; 18(11): 1707 - 1715. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Marx, G. Sukhova, C. Murphy, P. Libby, and J. Plutzky Macrophages in Human Atheroma Contain PPAR{gamma} : Differentiation-Dependent Peroxisomal Proliferator-ActivatedReceptor {gamma} (PPAR{gamma}) Expression and Reduction of MMP-9 Activitythrough PPAR{gamma} Activation in Mononuclear Phagocytes inVitro Am. J. Pathol., July 1, 1998; 153(1): 17 - 23. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.J. Davies Reactive Oxygen Species, Metalloproteinases, and Plaque Stability Circulation, June 23, 1998; 97(24): 2382 - 2383. [Full Text] [PDF] |
||||
![]() |
Z. S. Galis, K. Asanuma, D. Godin, and X. Meng N-Acetyl-Cysteine Decreases the Matrix-Degrading Capacity of Macrophage-Derived Foam Cells : New Target for Antioxidant Therapy? Circulation, June 23, 1998; 97(24): 2445 - 2453. [Abstract] [Full Text] [PDF] |
||||